The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers
Matthias Bartneck(DWI – Leibniz Institute for Interactive Materials), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum), Oliver Krenkel(Boehringer Ingelheim (Germany)), Anke Liepelt(Universitätsklinikum Aachen), Misti McCain(Newcastle University), Fabian Kießling(Universitätsklinikum Aachen), Olivier Govaere(VIB-KU Leuven Center for Microbiology), Dirk Eulberg(Noxxon Pharma (Germany)), Twan Lammers(RWTH Aachen University), Helen L. Reeves(Newcastle upon Tyne Hospital), Can Ergen(University of California, Berkeley), Tom Luedde(Düsseldorf University Hospital), Diana Möckel(RWTH Aachen University), Peter L. Schrammen(RWTH Aachen University)
Cited by 106
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k